Insulin resistance: signs, causes, testing and how to reverse it

Insulin resistance is one of the most common metabolic problems in adults, and most people who have it do not know. It can quietly shape energy, appetite, weight and long-term health for a decade or more before a blood sugar test flags anything.

If you feel tired after meals, struggle to lose weight despite real effort, or have been told your blood sugar is “a little high,” insulin resistance may be part of the picture. This guide brings everything together in one place: what insulin resistance is, the signs and symptoms (including prediabetes), what causes it, how it is tested, how it is treated and improved, how to lose weight with it, and when to see a clinician.

What insulin resistance is

Insulin is a hormone made by the beta cells of the pancreas. When you eat and blood glucose rises, insulin travels to cells in your muscles, liver and fat tissue and binds to receptors on their surface. That signal moves glucose transporters (called GLUT4) to the cell surface so glucose can enter and be used for energy or stored as glycogen. In a healthy system, modest amounts of insulin keep fasting glucose in a stable range of roughly 70 to 100 mg/dL.

Insulin does more than move glucose. It holds back the breakdown of stored fat, supports muscle protein building and signals fullness to the brain. As the Cleveland Clinic describes it, insulin is a building and storing hormone.

Insulin resistance means those target tissues respond poorly to insulin’s signal. Three tissues matter most:

• Skeletal muscle handles roughly 70% of insulin-mediated glucose uptake. When muscle resists insulin, more glucose stays in the blood. This is why muscle mass matters so much for metabolic health.
• The liver normally dials down its own glucose output when insulin rises. Even modest liver fat disrupts that signal, so the liver keeps releasing glucose and converts surplus glucose into more fat.
• Fat tissue, especially visceral fat around the organs, loses its restraint and releases free fatty acids and inflammatory signals. Those fatty acids build up in muscle, liver and pancreas, a state called lipotoxicity that deepens resistance.

Why it stays hidden for years

When cells resist insulin, the pancreas compensates by producing more. This state, called compensatory hyperinsulinemia, can keep fasting glucose normal for years while insulin levels climb. Standard glucose tests and even A1C can look fine. But the compensation is not sustainable. High insulin itself promotes fat storage and inflammation, and over time the strained beta cells lose function. When they can no longer keep up, glucose rises into the prediabetes range and then toward type 2 diabetes.

NCBI’s StatPearls notes that this silent window typically spans 10 to 15 years before type 2 diabetes develops. That window is the best time to act.

How common it is

A 2025 systematic review of 87 studies and 235,148 participants estimated a global pooled prevalence of about 26.53%, roughly one in four adults. In the US, an analysis of NHANES data found that about 40% of adults aged 18 to 44 without diabetes met HOMA-IR criteria for insulin resistance. UAB researchers found that nearly half of those young adults were not obese by BMI, and many already showed higher rates of high blood pressure and abnormal lipids.

Downstream, the CDC estimates that about 115.2 million US adults, roughly 38%, have prediabetes, and more than 8 in 10 of them do not know it. The age-adjusted prevalence of type 2 diabetes among US adults rose from 11.2% in 2001 to 2004 to 13.5% in 2021 to 2023.

Signs and symptoms of insulin resistance

Most people with early insulin resistance have no symptoms at all, as the American Diabetes Association and NIDDK both note. When signs do appear, they are indirect and easy to blame on stress, poor sleep or age. What matters is a pattern of several signs together, especially alongside risk factors.

Skin changes: dark patches and skin tags

Acanthosis nigricans is darkened, velvety, thickened skin in body folds such as the back of the neck, armpits and groin. High insulin stimulates skin cell growth and pigmentation, and its severity tracks with higher fasting insulin and HOMA-IR. It is more common in Black, Hispanic and Native American populations. Clusters of skin tags in the same areas are also linked to high insulin. Neither confirms a diagnosis, but both are a reason to ask for labs.

Fatigue, energy crashes and brain fog

When cells cannot use glucose efficiently, people often describe tiredness that does not improve with rest and a pronounced energy dip one to two hours after carbohydrate-heavy meals. The brain uses roughly 20% of the body’s glucose, so unstable supply can show up as slower thinking, poor concentration and brain fog, sometimes well before any diagnosis.

Hunger soon after eating and sugar cravings

Feeling hungry again within an hour or two of a full meal, with strong cravings for sweets and refined carbs, is a common pattern. Impaired insulin signaling weakens normal fullness signals and drives a cycle of quick-energy eating. As Baton Rouge General notes, this is physiology, not a willpower problem.

Weight gain around the middle

High insulin promotes fat storage and blocks fat breakdown, and the fat tends to settle around the abdominal organs. A waist circumference above 40 inches in men or 35 inches in women is a recognized marker of higher metabolic risk, even at a normal body weight.

Signs that show up on a lab report

Some of the clearest clues are measured, not felt. High triglycerides (150 mg/dL or higher) with low HDL cholesterol, blood pressure creeping up, and for women, irregular cycles or PCOS, can all point toward insulin resistance. Together with waist size and fasting glucose, these make up metabolic syndrome, a cluster that strongly implies underlying insulin resistance.

Prediabetes symptoms: usually none

Prediabetes is almost always found on routine bloodwork, not because someone felt unwell. Glucose rises slowly enough that the classic warning signs do not appear. The skin changes above may be present, but Mayo Clinic notes that many people with prediabetes show neither sign. Fatigue, thirst and brain fog overlap with so many other conditions that they cannot be used to self-diagnose.

Later-stage signs as blood sugar rises

As compensation fails, a more urgent set of symptoms can appear: increased thirst and frequent urination (glucose spills into urine once it exceeds roughly 180 mg/dL and draws water with it), blurred vision, slow-healing cuts and recurring infections such as yeast infections. These mean glucose is already elevated and call for prompt evaluation, not a wait-and-see approach.

Why women may miss the signs

In perimenopause, fatigue, poor sleep, mood shifts, brain fog and abdominal weight gain overlap almost completely with insulin resistance. UCLA Health highlights that prediabetes in women is often attributed to hormonal transition, which delays diagnosis. Falling estrogen also reduces insulin sensitivity on its own. Women in midlife, and women with PCOS at any weight, should ask for metabolic bloodwork rather than assume symptoms are only hormonal. We cover this further in our guide to perimenopause weight gain and metabolism.

Conditions that look similar

Fatigue, weight gain and cravings are also common in hypothyroidism, sleep apnea, depression, anemia, vitamin D or B12 deficiency, PCOS, perimenopause and chronic stress. That overlap is exactly why labs, not symptom checklists, are needed. Stony Brook Medicine also notes that many people with significantly elevated glucose have no symptoms at all.

Causes and risk factors

Insulin resistance rarely has a single cause. Several factors usually reinforce each other, and as Cleveland Clinic notes, acquired lifestyle factors account for most cases, which means the biggest levers are within reach.

• Excess visceral fat. The most potent modifiable driver. Visceral fat releases free fatty acids and inflammatory cytokines such as TNF-alpha and IL-6 that interfere with insulin signaling. The Obesity Medicine Association reports that roughly 70% of people with obesity show measurable insulin resistance, and each increase in visceral fat mass is linked to substantially higher odds of it. Central fat predicts risk better than BMI alone, as research in Experimental and Molecular Medicine highlights.
• Physical inactivity. Sedentary muscle loses GLUT4 transporters and mitochondrial capacity, shrinking the body’s main glucose sink.
• Diet. Frequent large glucose and insulin surges from refined carbohydrates, added sugars and ultra-processed foods promote sustained high insulin, visceral fat and inflammation.
• Poor sleep and chronic stress. Both raise cortisol, which opposes insulin and encourages visceral fat storage.
• Family history, PCOS and gestational diabetes. First-degree relatives of people with type 2 diabetes carry higher baseline risk. Estimates suggest 35% to 80% of women with PCOS have measurable insulin resistance. Prior gestational diabetes often signals a lasting predisposition.
• Age and medications. Muscle loss and accumulated inflammation raise risk with age. Glucocorticoids such as prednisone can induce or worsen insulin resistance.

Testing and diagnosis

There is no single universally adopted test for insulin resistance. Clinicians combine several measures and interpret them with your history and exam.

• Fasting glucose. 100 to 125 mg/dL indicates prediabetes.
• A1C. Reflects average glucose over two to three months; 5.7% to 6.4% indicates prediabetes. No fasting needed.
• Oral glucose tolerance test (OGTT). A two-hour result of 140 to 199 mg/dL indicates prediabetes. It can catch post-meal problems that fasting glucose misses.
• Fasting insulin and HOMA-IR. Insulin can rise years before glucose or A1C leave the normal range. HOMA-IR, calculated from fasting glucose and fasting insulin, is the most widely used clinical estimate. Values above roughly 2.0 to 2.5 are commonly read as suggestive of insulin resistance, though cutoffs vary.
• Lipid panel. A triglyceride-to-HDL ratio above about 3.0 in adults has been associated with a higher likelihood of insulin resistance.
• Waist and blood pressure. Waist above 40 inches (men) or 35 inches (women) and blood pressure at or above 130/80 mmHg add to the picture.

These prediabetes thresholds follow the American Diabetes Association’s diagnostic criteria, and a single abnormal result should be confirmed with repeat testing. The hyperinsulinemic-euglycemic clamp is the research gold standard but is not practical for routine care. For more on which labs to request, see our metabolic lab work guide.

Who should be screened

The US Preventive Services Task Force recommends screening adults aged 35 to 70 with overweight or obesity, and the ADA 2026 Standards of Care align with age 35 as the starting point. Asian American adults should be screened at a BMI of 23 or higher. Screen earlier or more often with a family history of type 2 diabetes, inactivity, high blood pressure, prior gestational diabetes, PCOS, sleep apnea, or African American, Hispanic and Latino, Native American or Pacific Islander background. Age matters on its own: the CDC estimates about 52% of adults 65 and older have prediabetes.

Why it matters: the bigger health picture

According to the CDC, insulin resistance drives an estimated 70% to 90% of type 2 diabetes cases. It is also linked to:

• Fatty liver disease (MASLD), formerly called non-alcoholic fatty liver disease, which can progress to inflammation and fibrosis.
• Cardiovascular disease, through high triglycerides, low HDL, small dense LDL particles, high blood pressure and arterial inflammation.
• PCOS, where high insulin drives excess androgens and the hormonal disruption worsens insulin sensitivity in return.
• Some cancers. A 2026 Nature Communications study of nearly 500,000 UK Biobank participants linked predicted insulin resistance to higher risk across 12 cancer types. These are associations, not proof of cause.

Can insulin resistance be reversed?

For many adults, yes, meaningfully. It is not fully reversible in everyone, but sustained changes can improve, slow or substantially reduce it, especially when started early. Yale School of Medicine research shows that modest weight loss reduces liver fat and can restore more normal insulin signaling. In the landmark Diabetes Prevention Program, an intensive lifestyle intervention cut new type 2 diabetes cases by 58% over about three years in high-risk adults, and benefits persisted at ten-year follow-up. The CDC’s National Diabetes Prevention Program builds on this, with structured lifestyle change reducing progression risk by about half.

Results vary with genetics, how long insulin resistance has been present, visceral fat, and conditions such as PCOS or sleep apnea. Some people return to near-normal markers; others make clinically meaningful gains without full resolution. Both are worth pursuing.

Treatment and how to reverse insulin resistance

Lifestyle change is the foundation, backed by the ADA, the CDC and the Cleveland Clinic. The levers work best together.

1. Eat for steadier glucose

No single named diet is proven best, according to both MD Anderson and the ADA. What matters is overall quality and a pattern you can keep:

• Fill half the plate with non-starchy vegetables, a quarter with lean protein and a quarter with whole grains or legumes, plus a moderate amount of olive oil, nuts or avocado.
• Choose fiber-rich, lower-glycemic carbohydrates. A 2025 meta-analysis found low-glycemic-index diets reduced HOMA-IR more than high-glycemic diets in adults without diabetes.
• Pair carbohydrates with protein, fat or fiber to slow absorption.
• Limit added sugars, sugary drinks, refined grains and ultra-processed foods. Fructose in particular drives liver fat.
• Keep meal timing regular rather than skipping meals and then eating a large carbohydrate-heavy meal.

Mediterranean-style eating has the strongest evidence. In the PREDIMED-Plus trial, a calorie-moderated Mediterranean diet with physical activity reduced type 2 diabetes risk by about 31% over six years. Our full insulin resistance and prediabetes diet guide covers foods, patterns and meal ideas in detail.

2. Move, and build muscle

Muscle contraction moves GLUT4 to the cell surface through a pathway that does not need insulin, so exercise lowers glucose even when insulin signaling is impaired. A single moderate session can improve insulin sensitivity for 24 to 72 hours, so regularity matters more than intensity.

• Aerobic: at least 150 minutes per week of moderate activity, per the American Diabetes Association.
• Resistance training: two to three sessions per week on nonconsecutive days. Squats, glute bridges, push-ups, lunges and bands are fine starting points; one to three sets of 8 to 15 repetitions is a practical framework.
• Post-meal walks: even 10 to 20 minutes after eating measurably lowers post-meal glucose.

Combined aerobic and resistance training consistently outperforms either alone.

3. Lose a modest amount of weight, if relevant

Losing 5% to 7% of body weight can significantly reduce liver fat and improve insulin sensitivity. For a 200-pound person, that is 10 to 14 pounds. Yale researchers found that even small amounts of liver fat impair insulin signaling and that modest weight loss can reverse this relatively quickly. Liver fat often drops before the scale moves much, so fasting glucose and insulin can improve within the first few weeks.

4. Protect sleep and manage stress

Sleep is a metabolic lever, not a soft one. A study in the Journal of Clinical Endocrinology and Metabolism found that one night of about four hours of sleep induced measurable insulin resistance, with the glucose infusion rate needed to hold normal blood sugar dropping by roughly 25%. A 2023 Columbia University trial found that cutting sleep by 1.5 hours a night for six weeks raised insulin resistance by nearly 15% in women, independent of weight. Aim for seven to nine hours on a consistent schedule, limit screens before bed and avoid late caffeine. Chronic stress keeps cortisol high, which opposes insulin and favors visceral fat; breathing exercises, mindful walking and short meditation help.

5. Medication, under a clinician’s care

No medication is FDA-approved specifically for insulin resistance as a standalone diagnosis. Medications are used within broader contexts such as diabetes prevention, obesity or metabolic syndrome, and eligibility is always decided by a licensed prescriber after a full evaluation.

• Metformin is the most studied insulin-sensitizing drug. In the Diabetes Prevention Program it reduced type 2 diabetes incidence by 31% over about 2.8 years in high-risk adults. It mainly lowers liver glucose output. See our full guide to metformin for insulin resistance.
• Thiazolidinediones such as pioglitazone improve sensitivity but carry risks including fluid retention, heart failure exacerbation and fractures, so they are reserved for selected cases.
• GLP-1 receptor agonists stimulate glucose-dependent insulin release, suppress glucagon, slow stomach emptying and reduce appetite. A 2024 Vanderbilt study in Diabetes found liraglutide improved HOMA-IR within two weeks, before meaningful weight loss. Research in the Journal of Clinical Endocrinology and Metabolism found only part of tirzepatide’s insulin-sensitivity improvement could be explained by weight loss.
• Bariatric surgery can improve insulin resistance within days to weeks for people with severe obesity, often before major weight loss.

Medication works best on top of lifestyle change. A 2025 meta-analysis of 33 randomized trials with more than 12,000 participants found that lifestyle modification plus GLP-1-class medication produced significantly greater reductions in weight, waist, A1C, fasting glucose, blood pressure and lipids than lifestyle plus placebo, with a mean weight difference above seven kilograms.

6. Track progress with labs

Fasting glucose, fasting insulin and HOMA-IR can show measurable change within weeks to months. Physician-guided monitoring every three to six months during active change, then annually once stable, turns guesswork into data. Gains fade if habits stop, so plan for the long term.

Losing weight with insulin resistance

Weight loss is genuinely harder with insulin resistance, and it has nothing to do with willpower.

Why it is harder

• Insulin keeps the fat-release switch off. Chronically high insulin tells fat cells to store energy and suppresses fat breakdown, even when calories are reduced.
• Visceral fat feeds the cycle. High insulin favors abdominal fat, and that fat releases inflammatory compounds that worsen insulin resistance, as research in Frontiers in Endocrinology describes.
• Hunger signals work against you. Glucose swings trigger hunger and carbohydrate cravings that undermine calorie control even in highly motivated people.
• Doing everything right can still stall. This hormonal override is why simple calorie-in, calorie-out advice underperforms.

What helps

• Protein at every meal. Roughly 20 to 30 grams per meal supports fullness, preserves muscle in a calorie deficit and has a lower insulin effect than refined carbohydrates.
• A moderate deficit, not a crash diet. About 500 to 750 calories per day preserves lean mass and metabolic rate. Extreme restriction triggers metabolic adaptation, rising hunger hormones and muscle loss.
• Strength training plus diet. Washington University research in Nature Metabolism found that combining exercise with about 10% weight loss more than doubled the improvement in whole-body insulin sensitivity compared with diet-driven weight loss alone. Resistance training is especially important during significant calorie restriction or while using a GLP-1 medication, to limit muscle loss.
• Sleep. Short sleep raises ghrelin, lowers leptin and pushes cravings toward fast carbohydrates.
• Medical support when effort stalls. For people who qualify, GLP-1 medication can make reaching the 5% to 10% threshold more attainable by reducing appetite and improving the hormonal environment. It complements, rather than replaces, the foundations above.

If progress has stalled despite consistent effort, our article on why weight loss stalls covers common causes.

When to see a clinician

Ask for a metabolic evaluation if you notice several of these together: central weight gain, persistent fatigue, post-meal crashes, skin changes, or abnormal lipids or blood pressure on recent labs. Do the same if you meet screening criteria and have not had bloodwork in the past one to three years. Seek prompt care for increased thirst, frequent urination, blurred vision or slow-healing wounds.

A thorough workup combines fasting glucose, fasting insulin, A1C, a lipid panel, blood pressure, waist circumference and a detailed personal and family history.

Elara offers physician-supervised metabolic health and weight management programs built around this model. Board-certified physicians review your history and labs, programs include quarterly lab monitoring and certified health coaching, and eligible patients may be prescribed compounded GLP-1 medication dispensed through licensed, accredited compounding pharmacies. Eligibility and treatment are determined individually by a licensed prescriber after a medical evaluation, and programs are not appropriate for everyone.

Supplements as a supporting role

Supplements are not treatments for insulin resistance. Under DSHEA, they can support structure and function, such as healthy glucose metabolism and energy, as part of a healthy lifestyle. Ingredients studied in this context include berberine, magnesium, alpha-lipoic acid and chromium, with effects that are generally modest and findings that are mixed. The National Center for Complementary and Integrative Health notes that none should be considered a standalone intervention. Magnesium glycinate is also used to support relaxation and sleep quality.

Elara’s supplement line is formulated to support metabolic health, energy and sleep as a complement to a healthy lifestyle and structured program. Talk with your clinician before adding any supplement, especially if you take prescription medication; berberine, for example, has side effects and interactions worth reviewing.

Frequently asked questions

Is insulin resistance the same as prediabetes?

No. Insulin resistance usually comes first, often with normal glucose because the pancreas is compensating. Prediabetes is diagnosed once glucose rises to a fasting level of 100 to 125 mg/dL, an A1C of 5.7% to 6.4% or a two-hour OGTT of 140 to 199 mg/dL. By then, insulin resistance is well established.

Can you have insulin resistance at a normal weight?

Yes. UAB research found nearly half of young adults with insulin resistance were not obese by BMI. Visceral fat, inactivity, poor sleep and family history can all drive it at a normal weight.

What is the best test for insulin resistance?

There is no single test. Fasting insulin with fasting glucose (to calculate HOMA-IR), A1C, a lipid panel and waist circumference together give the clearest picture.

How fast can insulin resistance improve?

Exercise improves insulin sensitivity for 24 to 72 hours after a session, and liver fat can fall within weeks of a moderate calorie deficit. Lab markers often shift within weeks to months of consistent change.

Do I need medication?

Not necessarily. Lifestyle change is the first-line approach for most people. Whether metformin, a GLP-1 medication or another option makes sense is decided individually by a licensed prescriber.

Can supplements reverse insulin resistance?

No. Some ingredients may support healthy glucose metabolism, but they are not a substitute for diet, activity, sleep and medical care.

Sources

• NCBI StatPearls: insulin resistance
• NCBI Bookshelf: insulin’s biochemical effects
• Global prevalence of insulin resistance, 2025 systematic review
• Insulin resistance in US adults aged 18 to 44 (NHANES)
• CDC: Insulin resistance and type 2 diabetes
• CDC: Prediabetes statistics
• NIDDK: Prediabetes and insulin resistance
• American Diabetes Association: Diagnosis
• Cleveland Clinic: Insulin resistance
• NCBI Bookshelf: acanthosis nigricans and insulin levels
• MedlinePlus: Metabolic syndrome
• Yale School of Medicine: How to reverse insulin resistance
• Low-glycemic-index diets and HOMA-IR, Frontiers in Nutrition 2025
• UCLA Health: Prediabetes in women

This content is for educational purposes only and does not constitute medical advice. Please consult a qualified healthcare provider to determine which interventions are appropriate for your individual health situation.

These statements have not been evaluated by the Food and Drug Administration. Elara supplements are not intended to diagnose, treat, cure, or prevent any disease.

Last updated October 12, 2026.